<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910812-0056</DOCNO><DOCID>910812-0056.</DOCID><HL>   Japanese Drug Company   Says It Falsified Test Data</HL><DATE>08/12/91</DATE><SO>WALL STREET JOURNAL (J), PAGE B2</SO><MS>CONSUMER NON-CYCLICAL (NCY)</MS><IN>DRUG MANUFACTURERS (DRG)</IN><RE>FAR EAST (FE)JAPAN (JA)NORTH AMERICA (NME)PACIFIC RIM (PRM)UNITED STATES (US)</RE><LP>   TOKYO -- Otsuka Pharmaceutical Co. confirmed reports thatit falsified test data on a heart disease drug sold in Japan.   A company spokesman said Monday that the company has alsobeen testing the drug -- vesnarinone, or Arkin-Z -- in theU.S. since 1986, and hopes to complete the tests by early1993. He stressed that only a small portion of the data hadbeen falsified in Japan, and that that will not affect plansfor sales in the U.S.</LP><TEXT>   Japanese news reports said the Japanese Ministry of Healthand Welfare began investigating the drug after more than 40patients suffered a drop in white blood cell count and fourdied from various complications.   The company said that one employee falsified 10 of thecompany's 13,000 test records of the drug by saying that thedrug showed no side effects during testing.   Otsuka, based in Osaka, has been selling a drug calledCartrol to treat circulatory problems in the U.S. since 1989.</TEXT></DOC>